Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

HCW Biologics (HCWB) Operating Expenses (2020 - 2025)

HCW Biologics (HCWB) has disclosed Operating Expenses for 6 consecutive years, with $3.3 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Operating Expenses fell 13.29% year-over-year to $3.3 million, compared with a TTM value of $12.0 million through Sep 2025, down 68.72%, and an annual FY2024 reading of $30.4 million, up 15.84% over the prior year.
  • Operating Expenses was $3.3 million for Q3 2025 at HCW Biologics, down from $3.5 million in the prior quarter.
  • Across five years, Operating Expenses topped out at $15.3 million in Q2 2024 and bottomed at $2.0 million in Q1 2025.
  • Average Operating Expenses over 5 years is $5.1 million, with a median of $3.8 million recorded in 2024.
  • The sharpest move saw Operating Expenses skyrocketed 230.74% in 2024, then plummeted 77.37% in 2025.
  • Year by year, Operating Expenses stood at $3.1 million in 2021, then surged by 90.7% to $5.9 million in 2022, then soared by 85.68% to $11.0 million in 2023, then crashed by 70.51% to $3.2 million in 2024, then rose by 0.75% to $3.3 million in 2025.
  • Business Quant data shows Operating Expenses for HCWB at $3.3 million in Q3 2025, $3.5 million in Q2 2025, and $2.0 million in Q1 2025.